Last edition
News about "Deucravacitinib"
Autoimmune drug by Bristol Myers shows potential in lupus
Deucravacitinib is one of nine new drugs that Bristol Myers executives believe will help offset revenue losses
Deucravacitinib | 08/06/2022 | By Sudeep Soparkar | 597
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members